US Patent 11590228 Extended release amphetamine compositions
Patent 11590228 was granted and assigned to Tris Pharma on February, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11590228 Extended release amphetamine compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
